Personal Profile:

August 1998 – Present: Associate Professor, Professor, Doctoral Supervisor, School of Medicine, Jinan University

July 1985 – July 1998: Teaching Assistant, Lecturer, Associate Professor, Department of Laboratory Medicine, Bengbu Medical University

Main Research Directions:

Focus on molecular biology of viral pathogenesis and immunity, infectious immunity, and tumor immunity.

Has published more than 80 SCI papers, among which co-first author and corresponding author papers have been published in journals including Cell Reports, Signal Transduction and Targeted Therapy, Small, etc.

Zhenyou Jiang, Professor

School of Medicine,

Jinan University

Ⅰ.Representative academic achievements:

Zhenyou Jiang* (Co-corresponding Author). Targeting VCP potentiates immune checkpoint therapy for colorectal cancer. Cell Reports. 2023, 42(11): 113318. https://doi.org/10.1016/j.celrep.2023.113318. (Cell Sub-journal, SCI A1, JCR Q1, Impact Factor: 8.2)

Zhenyou Jiang† (Co-first Author). Study on the promotion of lymphocytes in patients with COVID-19 by broad-spectrum chemokine receptor inhibitor vMIP-II and its mechanism of signal transmission in vitro. Signal Transduction and Targeted Therapy. 2021, 6(1): 104. https://doi.org/10.1038/s41392-021-00516-4. (SCI A1, JCR Q1, Impact Factor: 38.18)

Zhenyou Jiang* (Co-corresponding Author). Photothermal and Enhanced Photocatalytic Therapies Conduce to Synergistic Anticancer Phototherapy with Biodegradable Titanium Diselenide Nanosheets. Small. 2021, 17(40): 2103239. (SCI A1, JCR Q1, Impact Factor: 15.15)

Ⅱ. Presided National Research Projects:

1.General Program of National Natural Science Foundation of China (No. 82074133): Study on the immune regulatory mechanism and active components of Xinjia Xiangru Yin in the treatment of summer-damp type influenza. Funding: 550,000 RMB

2.The 12th Five-Year National Science and Technology Major Project for Infectious Diseases of China (No. 2014ZX10003002): Study on nanotechnology-based detection of interleukin-22 and other biomarkers for the diagnosis of latent tuberculosis infection. Funding: 1,877,500 RMB

3.General Program of National Natural Science Foundation of China (No. 81473454): Study on the regulatory mechanism of TLR7/NF-κB and RLH signal transduction in FM1 influenza mice under different feeding environments by prescriptions with different therapeutic methods. Funding: 720,000 RMB

4.The 13th Five-Year National Science and Technology Major Project for Infectious Diseases of China (No. 2018ZX10715004-002): Field epidemiological study on comprehensive community intervention for tuberculosis. Funding: 250,300 RMB

5.The 12th Five-Year National Science and Technology Major Project for Infectious Diseases of China (No. 2013ZX10003001): Development of ultra-sensitive POCT products for Mycobacterium tuberculosis latent infection diagnosis based on nano-immuno-electro-sensing technology. Funding: 390,000 RMB

E-mail: tjzhy@jnu.edu.cn